Inteum Company
Links
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - lili+he
69
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Architecture and Level 2 Variable Power Control Scheme (Case No. 2013-146)
Summary: UCLA researchers in the Department of Mechanical & Aerospace Engineering have developed a smart EV charging architecture that dynamically optimizes EV charging loads based on real-time grid capacity and limitations. Background: The rapid increase in electric vehicle (EV) adoption creates a critical need for robust and accessible charging...
Published: 4/7/2026
|
Updated: 4/7/2026
|
Inventor(s):
Rajit Gadh
,
Ching Yen Chung
,
Chi Cheng Chu
,
Li Qiu
Keywords(s):
Charge Carrier
,
charge collection
,
charge collection efficiency
,
charge extraction
,
charge sharing
,
charge summing
,
charged particle beams
,
charge-transfer
,
Electric Current
,
Electric Vehicle
,
electric vehicle charging
,
Electrical
,
Electrical Impedance
,
Electrical Load
,
Energy Harvesting Evaporation
,
EV battery cooling
,
grid efficiency
,
grid energy
,
Power distribution & grids
,
Rechargeable Battery
,
Rechargeable Battery Thermal Conductivity
,
Smart Grid
,
supercharger
,
Surface Charge
,
vehicle charging
Category(s):
Electrical
,
Energy & Environment
,
Energy & Environment > Energy Efficiency
,
Energy & Environment > Energy Generation
,
Energy & Environment > Energy Storage
,
Energy & Environment > Energy Transmission
Engineered Gamma Delta T-Cells and Methods of Making and Using Thereof (UCLA Case No. 2020-913)
UCLA researchers in the Department of Molecular Immunology & Molecular Genetics have developed gamma delta (gd) T cell receptor gene-modified immune cells derived from stem and progenitor cells that enable scalable, off-the-shelf allogeneic cell therapies with broad therapeutic potential. BACKGROUND: Cell-based immunotherapies have demonstrated...
Published: 3/4/2026
|
Updated: 3/4/2026
|
Inventor(s):
Lili Yang
,
Derek Lee
,
Tyler Halladay
Keywords(s):
Category(s):
Diagnostic Markers > Immunology
,
Diagnostic Markers > Cancer
,
Life Science Research Tools > Cell Lines
,
Therapeutics > Oncology
,
Therapeutics > CNS and Neurology
,
Therapeutics > Hematology
,
Therapeutics > Autoimmune
,
Therapeutics > Gene Therapy And Editing
,
Therapeutics > Stem Cells And Regenerative Medicine
,
Therapeutics > Infectious Diseases
Electrotherapy for dental implants
In Situ electrochemical repassivation therapy of titanium dental implants can restore corrosion resistance and enhance cellular biocompatibility. Invention Summary: Peri-implantitis affects up to 25% of dental implant patients and is a leading cause of implant failure, representing a global market burden exceeding $1B annually. Current treatments...
Published: 3/10/2026
|
Updated: 2/20/2026
|
Inventor(s):
Georgios Kotsakis
,
Li Xie
Keywords(s):
Category(s):
Technology Classifications > Healthcare & Life Sciences
,
Technology Classifications > Dental
Impact energy assessment through data fusion
Reference #: 1733 The University of South Carolina is offering licensing opportunities for Impact energy assessment through data fusion. Background: When a material is subjected to external forces or internal stress, its internal structure gradually accumulates energy. In composite materials, for example, this process can result in fiber breakage...
Published: 4/24/2026
|
Updated: 2/17/2026
|
Inventor(s):
Li Ai
,
Paul Ziehl
Keywords(s):
Category(s):
Engineering and Physical Sciences
Assessment of impact localization and energy
Reference #: 1711 The University of South Carolina is offering licensing opportunities for Assessment of impact localization and energy. Background: When a material is subjected to external forces or internal stress, its internal structure gradually accumulates energy. In composite materials, for example, this process can result in fiber breakage...
Published: 3/25/2026
|
Updated: 2/17/2026
|
Inventor(s):
Paul Ziehl
,
Li Ai
Keywords(s):
Category(s):
Software and Computing
Transgenic Mouse Model for Marfan Syndrome Research
Description: A genetically modified mouse model carrying the FBN1Q2469X mutation enables advanced study of systemic Marfan Syndrome manifestations and therapeutic development. This innovative transgenic mouse model incorporates a mutation analogous to the human FBN1Q2467X gene mutation linked to Marfan Syndrome, resulting in fibrillin-1 deficiency...
Published: 12/23/2025
|
Updated: 12/23/2025
|
Inventor(s):
Li Li
,
Shichao Wu
,
Jiawei Zhao
Keywords(s):
Category(s):
Technology Category > Research tools
,
Technology Category > Animal models
,
Technology Category > Biology
,
Technology Category > Diagnostic
IL-2 Independent Ultrahigh Human T Cell Activations Through Biomimetics of Immune Synapses by Graphene Oxides (UCLA Case No. 2021-068)
UCLA researchers in the Department of Materials Science and Engineering have constructed a novel graphene oxide-based platform for robust T cell activation through artificial immune synapse formation. BACKGROUND: T cells are a critical arm of the immune system with tremendous therapeutic value for immune disorders and cancer. However, modulation of...
Published: 10/2/2025
|
Updated: 10/2/2025
|
Inventor(s):
Yu Huang
,
Lili Yang
Keywords(s):
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
Engineered Mucosal-Associated Invariant T (MAIT) Cells and Methods of Making and Using Thereof (UCLA Case No. 2024-055)
UCLA researchers in the Department of Microbiology Immunology and Molecular Genetics have developed a novel platform and methodology for the production of mucosal-associated invariant T (MAIT) cells for therapeutic use in infectious diseases, autoimmune disorders, and cancer. BACKGROUND: Mucosal-associated invariant T (MAIT) cells are a subset of...
Published: 7/31/2025
|
Updated: 7/31/2025
|
Inventor(s):
Lili Yang
Keywords(s):
Category(s):
Therapeutics > Oncology
,
Therapeutics > Infectious Diseases
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Autoimmune
Chemically Modified AMPA Receptor RNA Aptamers Designed for In Vivo Use
" RNA aptamers as glutamate agonists offer potential therapeutics for a range of neurological disorders RSS.HDBackground> Background: < Neurological disorders are increasingly recognized as major causes of death and disability worldwide. Nearly 500,000 cases of brain tumor, multiple sclerosis, and amyotrophic lateral sclerosis (ALS) are...
Published: 1/30/2026
|
Updated: 5/13/2025
|
Inventor(s):
Li Niu
,
Zhen Huang
Keywords(s):
Technologies
Category(s):
Technology Classifications > Screens and Assays
,
Technology Classifications > Research Tools and Reagents
,
Campus
,
Campus > University at Albany
Potent and Selective Inhibition of a Single AMPA Receptor Subunit by an RNA Aptamer
Inhibitors of AMPA type glutamate ion channels for the treatment of neurological disorders such as ALS, Alzheimer's, and Parkinson's. Background: Ionotropic glutamate receptors (iGluRs) play special roles in brain activities, such as memory and learning, and have been implicated in a variety of neurological diseases, such as post-stroke cellular...
Published: 1/30/2026
|
Updated: 5/13/2025
|
Inventor(s):
Li Niu
,
Zhen Huang
,
Yan Han
,
Congzhou Wang
,
Jae Seon Park
Keywords(s):
RNA
,
Technologies
Category(s):
Technology Classifications > Biomedical Science and Engineering
,
Campus
,
Campus > University at Albany
1
2
3
4
5
6
7